找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drugs between Research and Regulations; Proceedings of the 5 C. Steichele (Medizinischer Direktor),U. Abshagen Conference proceedings 1985

[復制鏈接]
樓主: 無感覺
11#
發(fā)表于 2025-3-23 12:24:24 | 只看該作者
https://doi.org/10.1007/978-1-4842-4950-5sons and, at least in Italy, the law prevent the GP from taking a direct part in the first phases of clinical research; on the other hand, even after the introduction of a medicine onto the market, the general practitioner’s involvement is considered to be that of prescription rather than evaluation.
12#
發(fā)表于 2025-3-23 16:21:52 | 只看該作者
Installing Third-Party Libraries,linical trials, with special reference to drug evaluation after marketing (Phase IV). I shall deal with it from the vantage of a decade and a half of consultation work in this area, especially with the Drug Epidemiology Unit of Boston University School of Medicine.
13#
發(fā)表于 2025-3-23 19:48:03 | 只看該作者
Clinical guidelines — a help or a hindrance?cceed, now and again, in thwarting their deliberations and obscuring their aims. The issue of Guidelines for the Clinical Investigation of Drugs is a case in point. They are hailed by some and condemned by others and nine tenths of the problem is that the one party really has little idea what the other party is talking about.
14#
發(fā)表于 2025-3-23 23:51:22 | 只看該作者
15#
發(fā)表于 2025-3-24 03:04:13 | 只看該作者
Alternatives to clinical trials in post-marketing research on drug effectslinical trials, with special reference to drug evaluation after marketing (Phase IV). I shall deal with it from the vantage of a decade and a half of consultation work in this area, especially with the Drug Epidemiology Unit of Boston University School of Medicine.
16#
發(fā)表于 2025-3-24 07:28:05 | 只看該作者
Managing Device Drivers and PC ResourcesRisk: benefit decision making lies at the heart of modern therapeutics, and it is possible to distinguish between four categories of problem.
17#
發(fā)表于 2025-3-24 10:44:29 | 只看該作者
18#
發(fā)表于 2025-3-24 14:49:36 | 只看該作者
The organisation of long-term intervention and prevention studiesRisk: benefit decision making lies at the heart of modern therapeutics, and it is possible to distinguish between four categories of problem.
19#
發(fā)表于 2025-3-24 20:33:56 | 只看該作者
20#
發(fā)表于 2025-3-25 00:30:33 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-28 23:49
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
兴城市| 丹棱县| 湖北省| 巴彦淖尔市| 西青区| 怀远县| 安仁县| 淄博市| 青冈县| 阜城县| 卫辉市| 榆树市| 洛宁县| 临城县| 施甸县| 临沂市| 金昌市| 辽阳县| 峨眉山市| 安远县| 宁明县| 长阳| 巴南区| 台南县| 宁德市| 灵山县| 洱源县| 和顺县| 勐海县| 林口县| 普安县| 石嘴山市| 普陀区| 宿迁市| 丁青县| 泽普县| 巩留县| 闽侯县| 镇康县| 贡山| 北辰区|